AzTrials
AzTrials

Gastrostomy TubeNCT05173935

Complications Associated With Primary Placement of Gastrostomy for Feeding

A study testing Percutaneous endoscopic gastrostomy and Radiologically-inserted gastrostomy in people with Gastrostomy Tube, run by Mayo Clinic at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of the study is to compare pain, complications, and quality of life after gastrostomy tube is placed by either percutaneous endoscopic gastrostomy (PEG) or radiologically-inserted gastrostomy (RIG) method. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Gastrostomy Tube
What is being tested?
Percutaneous endoscopic gastrostomy and Radiologically-inserted gastrostomy
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
43 participants
Where
1 siteUnited States
Study dates
8 Dec 2017to 29 Jul 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age greater than or equal to 18 years
  • Cannot maintain adequate nutrition by mouth

Who cannot join

  • Venting-only gastrostomy
  • Patients with Amyotrophic Lateral Sclerosis (ALS)
  • Coagulopathy with uncorrectable International Normalized Ratio (INR) greater than 1.5 or inability to hold anticoagulation
  • Structural abnormality that would prevent one or both techniques
  • Known severe esophageal stricture
  • Obstructing malignancy in oropharynx or esophagus that prohibits pull-through technique
Show all 17Show fewer
  • Neoplastic, inflammatory, or infiltrative disease of abdominal wall or gastric wall
  • Known hepatomegaly
  • Abdominal wall mesh
  • Enteric functional abnormality
  • Small bowel or colonic obstruction
  • Gastric or small bowel dysmotility
  • Active abdominal infection/peritonitis/enterocutaneous fistula
  • Ascites
  • Ventriculoperitoneal shunt
  • Inpatient status
  • Pregnant patient

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Mayo Clinic in Rochester

    Rochester, Minnesota, 55905

Other trials in United States

About this study

Official title: Complications Associated With Primary Placement of Radiologically-Inserted Gastrostomy Versus Percutaneous Endoscopic Gastrostomy for Feeding

The purpose of the study is to compare pain, complications, and quality of life after gastrostomy tube is placed by either percutaneous endoscopic gastrostomy (PEG) or radiologically-inserted gastrostomy (RIG) method.

Read the detailed description

Objectives:

Primary objectives: to assess 1) pain and 2) major and minor complications with gastrostomy-tube placement, comparing RIG with PEG

Secondary objectives:

  • To compare costs associated with each technique
  • To compare anesthesia type used with each technique
  • To assess patient quality of life before and after the procedure

Co-primary outcome measures:

Efficacy Outcome - Trajectory of the average pain score (question 3, Cleeland Brief Pain Inventory) through Week 6

Statistical Null Hypothesis: The model-based estimates of the pain scores trajectories will be co-incident for the two placement approaches RIG compared to PEG.

Safety Outcome - Minor and major complication rate per participant

Statistical Null Hypothesis: The percentage of participants with at least one major or minor complication will be equal between RIG and PEG groups

Methods:

All participants meeting criteria for placement of gastrostomy tube for nutrition and not having any exclusion criteria will be prospectively randomized at the initial Home Enteral Nutrition (HEN) visit with physician, nurse and dietician. The randomization will be performed with the use of a 4-block randomization tool, based on the inclusion criteria and will not be intentionally matched for other demographics. Participants will be randomized to either undergo RIG with an Interventional Radiologist or PEG with a Gastroenterologist. Sixty-four participants will be randomized into each group for a total accrual of 128 patients. Participants will be randomized to receive one of two widely-accepted standards of care. The research component will involve the use of questionnaires during routine post-placement follow-up to assess for pain, quality of life, and complications.

Radiologic technique:

Radiologically-inserted gastrostomy (RIG) tubes are placed in one of three ways: either using 1) a balloon to dilate the tract without gastropexy T-fasteners, 2) a balloon to dilate the tract with gastropexy T-fasteners or 3) a peel-away sheath with gastropexy T-fasteners. All of the procedures occur in the interventional radiology procedural suite and are performed after informed consent is obtained. The participant receives weight-based antibiotics intravenously. A temporary small nasogastric or orogastric tube is placed if one is not in place. Suitable site for percutaneous access into the stomach is localized on the abdomen, sometimes with the use of ultrasound to mark the liver edge. Participants may or may not have had a CT scan of the abdomen for stomach localization prior to the placement. The abdomen is prepped and draped in the usual sterile fashion. Local anesthesia alone or with the addition of moderate sedation, monitored anesthesia care, or general anesthesia is administered, depending on the needs of the participant. Participant may or may not receive intravenous glucagon. Air is insufflated into the stomach through the nasogastric tube under fluoroscopic guidance. One percent lidocaine for local anesthesia is instilled at the desired gastrostomy site and at the sites of T-fasteners, if used. An 18-gauge or micropuncture needle is advanced into the insufflated stomach under fluoroscopic guidance. Air is aspirated, and contrast medium is injected to confirm the intraluminal location of the needle(s). A stiff guidewire is advanced into the stomach or through the stomach to the ligament of Treitz. For the balloon-dilatation technique, the tract is dilated with a balloon, the gastrostomy tube is advanced into the stomach using the balloon in coaxial fashion, and then the dilating balloon is removed. For the technique that uses a peel-away sheath, the tract is serially dilated over the wire, and a peel away sheath is advanced over the wire into the stomach. For both techniques, a 16- or 18-French balloon-style gastrostomy tube is then advanced into the stomach lumen, and the guide wire is removed. If T-fasteners are used, they are then secured to the participant's skin. T-fasteners are designed to fall off at six weeks. The nasogastric tube is removed at the end of the procedure. Participants may use the tube for water and medications at two hours and may use the tube for feedings no sooner than four hours, but only after appropriate Home Enteral Nutrition follow-up.

Endoscopic technique:

All PEG placements are performed with anesthesia support and after informed consent is obtained. After the participant is appropriately sedated and antibiotic prophylaxis is given, the standard adult gastroscope is passed orally and a routine esophagogastroduodenoscopy (EGD) is performed to assess for any unknown pathology and to characterize if appropriate apposition of the anterior gastric wall and the abdominal wall can be accomplished. This requires insufflation of air or carbon dioxide through the scope and then palpation of the abdominal wall and/or observation of the abdominal wall for light trans-illumination to identify the site of best apposition of the two walls. This site is marked and then cleansed. Local lidocaine is infiltrated and a small stab wound may be made at the discretion of the endoscopist. Using sterile technique a needle is passed through the abdominal wall into the gastric lumen as observed endoscopically. Through this needle is passed a looped flexible wire which is grasped with a snare introduced through the scope and the wire is withdrawn out the mouth as the scope is removed. A 20-French gastrostomy tube is attached to the looped wire and the wire is pulled from the abdominal wall so the tube is pulled through the mouth and down the esophagus into the stomach and out the abdominal wall. The tube is pulled into position until the inner bumper is noted to be at the abdominal wall. The faceplate is then placed over the external tube to maintain position. At the discretion of the endoscopist the scope may be passed once more into the stomach to ensure proper positioning of the tube. The tube may be used for fluid or feedings at 4 hours after initial placement, but only after appropriate Home Enteral Nutrition follow-up.

Independent of whether RIG or PEG is placed, the participants will be followed by the Home Enteral Nutrition clinic, using the following protocol:

  1. Face-to-face visit with HEN nurse for site care and tube education and with HEN dietitian for instruction about provision of supplies and for administration of the first feeding together, to occur within 24 hours post-procedure.
  2. Phone call or secure message at 48-86 hours post-procedure to answer questions and ensure proper progression of feeding.
  3. Phone call or secure message or face-to-face visit 6 weeks post-procedure.
  4. Face-to-face visit with HEN dietitian and nurse for tube exchange, at 3 months for RIG and 9 months for PEG, if needed, for first tube replacement.

Length of study: Participants will be followed until tube removed or until 9 months, whichever is shorter.

Data Collection:

Study data collected will include pain, major and minor complications, quality of life, rates of early exchange of tube, and costs associated with each procedure.

Being tested
Percutaneous endoscopic gastrostomy, Radiologically-inserted gastrostomy
Keywords
complication, quality of life, pain
Medical subject headings
Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Percutaneous endoscopic gastrostomyProcedure or surgery

    Gastrostomy tube placement using an endoscopic camera inserted via the mouth into the stomach to place the tube.

  • Radiologically-inserted gastrostomyProcedure or surgery

    Gastrostomy tube placement using a temporary nasogastric tube placed from nose to stomach and fluoroscopy (x-rays).

Study groups in NCT05173935
Study groupRoleWhat they receive
PEG GroupActive comparatorSubjects will gastrostomy tube placement via percutaneous endoscopic gastrostomy (PEG) method.
Receives: Procedure: Percutaneous endoscopic gastrostomy
RIG GroupActive comparatorSubjects will have the placement of a gastrostomy tube via radiologically-inserted gastrostomy (RIG) method.
Receives: Procedure: Radiologically-inserted gastrostomy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in pain with gastrostomy-tube placement, comparing RIG with PEG

    Trajectory of the average pain score over time (question 3, Cleeland Brief Pain Inventory), which rates average pain in the past 24 hours, with 0 being no pain and 10 being pain as bad as can be imagined

    Measured: Before the procedure, within 24 hours after procedure, at 48-96 hours after procedure, and at 6 weeks after procedure

  2. Major and minor complications with gastrostomy-tube placement, comparing RIG with PEG

    Assessment of the following major complications after procedure: Peritonitis, Abscess, Major bleeding requiring intervention and/or transfusion, Bowel perforation, Death; Assessment of the following minor complications after procedure: Minor bleeding, not requiring transfusion, Tube occluded, Tube malpositioned/fell out,Tube damaged, Skin erosion, Site redness, Site nodules/induration, Site exudate

    Measured: Within 24 hours after procedure

  3. Major and minor complications with gastrostomy-tube placement, comparing RIG with PEG

    Assessment of the following major complications after procedure: Peritonitis, Abscess, Major bleeding requiring intervention and/or transfusion, Bowel perforation, Death; Assessment of the following minor complications after procedure: Minor bleeding, not requiring transfusion, Tube occluded, Tube malpositioned/fell out,Tube damaged, Skin erosion, Site redness, Site nodules/induration, Site exudate

    Measured: At 6 weeks after procedure

  4. Minor complications with gastrostomy-tube placement, comparing RIG with PEG

    Assessment of the following complications after procedure: Tube occluded, Tube malpositioned/fell out, Tube damaged, Skin erosion, Site redness, Site nodules/induration, Site exudate

    Measured: At 3 months, if tube still in place

  5. Minor complications with gastrostomy-tube placement, comparing RIG with PEG

    Assessment of the following complications after procedure: Tube occluded, Tube malpositioned/fell out, Tube damaged, Skin erosion, Site redness, Site nodules/induration, Site exudate

    Measured: At 6 months, if tube still in place

  6. Minor complications with gastrostomy-tube placement, comparing RIG with PEG

    Assessment of the following complications after procedure: Tube occluded, Tube malpositioned/fell out, Tube damaged, Skin erosion, Site redness, Site nodules/induration, Site exudate

    Measured: At 9 months, if tube still in place

Secondary outcomes (4)
  1. Costs associated with gastrostomy tube placement, comparing RIG with PEG

    Tally of costs associated.

    Measured: Immediately after procedure completion

  2. Anesthesia type associated with gastrostomy tube placement, comparing RIG with PEG

    Documentation of the types of anesthesia used during procedure

    Measured: Immediately after procedure completion

  3. Patient quality of life associated with gastrostomy tube placement, comparing RIG with PEG, before and after the procedure

    Measurement of the patient quality of life using the Short Form-8 Quality of Life (SF-8 QOL) inventory in which eight questions with five or six possible descriptive word answers exist, with the first answer of each question meaning a better outcome and the last answer of each question meaning a worse outcome

    Measured: Before the procedure

  4. Patient quality of life associated with gastrostomy tube placement, comparing RIG with PEG, before and after the procedure

    Measurement of the patient quality of life using the Short Form-8 Quality of Life (SF-8 QOL) inventory in which eight questions with five or six possible descriptive word answers exist, with the first answer of each question meaning a better outcome and the last answer of each question meaning a worse outcome

    Measured: At 6 weeks after procedure

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Dec 2021
  2. Study start8 Dec 2017
  3. Primary completion29 Jul 2021
  4. Study completion29 Jul 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
43 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05173935
Sponsor's protocol ID
16-010077
Status last verified
Jan 2023
First submitted
29 Nov 2021
Last updated
11 Jan 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Percutaneous endoscopic gastrostomy and Radiologically-inserted gastrostomy in people with Gastrostomy Tube, run by Mayo Clinic at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 17 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Jan 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in pain with gastrostomy-tube placement, comparing RIG with PEG (time frame: Before the procedure, within 24 hours after procedure, at 48-96 hours after procedure, and at 6 weeks after procedure). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Jan 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in